
Board Meeting20 Jul 2026, 09:00 am
Divis Laboratories Board Meeting on Aug 1 to Approve Q1 FY27 Results
AI Summary
Divis Laboratories Ltd has announced that its Board of Directors will convene on August 1, 2026. The primary agenda item is to consider and approve the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. Concurrently, the trading window for the company's securities, which was closed from July 1, 2026, will remain shut until 48 hours after the declaration of these financial results, extending its closure until August 3, 2026.
Key Highlights
- Board meeting scheduled for August 1, 2026.
- To approve unaudited financial results for Q1 FY27.
- Results will be standalone and consolidated.
- Trading window closure extended until August 3, 2026.
Price Impact
More from DIVISLAB
Quarterly Result7 Nov, 12:30 pm
Divis Laboratories Declares Q2 FY27 Unaudited Financial Results
Quarterly Result7 Nov, 12:00 pm
Divi's Labs consolidated PAT surges 64% YoY to ₹1,127 Cr, margins hit record 42.6%
Board Meeting22 Oct, 5:00 pm
Divis Laboratories Board Meeting on Nov 7, 2026 for Unaudited Results